EUCTR2008-007104-28-SE进行中（未招募）不适用
Multiferon treatment of non-responders to peg-IFN alfa plus ribavirin standard of care treatment - a study of the early viral kinetics during the initial 12 weeks treatment. - IFN-Multiferon08
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •10-20 patients earlier treated with peg-IFN alfa-2a 180 mcg q.w. in combination with RBV dosed 1000/1200 mg per day (weight <75/>75 kg) in whom results of HCV RNA quantification at baseline, week 4 and 12 as measured by the TaqMan Roche test (sensitivity 15 IU/mL) are available will be recruited.
- •These patients have a well documented prior treatment but should have failed to achive EVR treatment week 12 during SOC treatment.
- •Are the trial subjects under 18?
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with concomitant diseases/conditions which are contraindications for treatment with IFN and ribavirin
研究者
相似试验
已完成
4 期
Response-Guided Interferon Therapy for patients with chronic hepatitis C of the Genotype 1 high viral load: Japanese multi-center, randomized controlled study: (ReGIT-J study)Chronic hepatitis CJPRN-UMIN000002748Hyogo College Of Medicine300
已完成
不适用
Interferon (IFN) induction followed by PEG-interferon combined with ribavirin and amantadine for treatment of naive chronic hepatitis C patients with genotype 1 or 4Hepatitis C virus (HCV)Infections and InfestationsChronic viral hepatitisISRCTN59358441Academic Medical Centre (AMC) (Netherlands)58
已完成
不适用
Combination therapy using pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C virus (HCV) infection 3 to 120 months after liver transplantatioHepatitis C reinfection after liver transplantationInfections and InfestationsChronic viral hepatitisISRCTN51477478Hannover Medical School (Medizinische Hochschule Hannover) (Germany)75
进行中（未招募）
不适用
COMBINED THERAPY WITH PEG-INTERFERON-a, RIBAVIRIN AND RITUXIMAB OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA - NDpatients anti-HCV, HCV RNA positivity, Na?ve, with cryoglobulinemic vasculitis (detection of serum cryoglobulins associated with purpura, arthralgias and weakness)and with chronic hepatitisMedDRA version: 9.1Level: SOCClassification code 10005329EUCTR2010-020659-30-ITAZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
进行中（未招募）
1 期
Cell based immune therapy for patients with skincancermalignant melanomaMedDRA version: 18.1Level: LLTClassification code 10027481Term: Metastatic melanomaSystem Organ Class: 100000004864EUCTR2014-001420-29-DKCenter for Cancer Immune Therapy20